FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160022288> ?p ?o ?g. }

• W2160022288 endingPage "1601" @default.
• W2160022288 startingPage "1595" @default.
• W2160022288 abstract "Abstract Background: The surface epithelial glycoprotein MUC1 becomes overexpressed and hypoglycosylated in adenocarcinomas; similar changes occur during nonmalignant inflammatory events. Antibodies developed against tumor-like MUC1 in response to such events could be one way through which ovarian cancer risk factors operate. Methods: We evaluated the association between anti-MUC1 antibodies and risk of ovarian cancer in a prospective nested case-control study in the Nurses' Health Studies. We used an ELISA to measure plasma anti-MUC1 antibodies in 117 ovarian cancer cases collected at least 3 years before diagnosis and 339 matched controls. Results: In controls, younger women (P-trend = 0.03), those with a tubal ligation (P = 0.03), and those with fewer ovulatory cycles (P-trend = 0.04) had higher antibody levels. In cases, women with late-stage disease (P = 0.04) and those whose specimen was &gt;11 years remote from diagnosis (P = 0.01) had higher antibody levels. Overall, increasing anti-MUC1 antibody levels were associated with a nonsignificant trend for lower risk for ovarian cancer, but there was highly significant heterogeneity by age (P-heterogeneity = 0.005). In women &lt;64 years, the antibody level in quartiles 2 to 4 versus quartile 1 were associated with reduced risk (relative risk = 0.53; 95% confidence interval, 0.31-0.93; P-trend = 0.03), whereas in women ≥64 years, the corresponding relative risk was 2.11 (95% confidence interval, 0.73-6.04); P-trend = 0.05). Conclusion: Anti-MUC1 antibodies evaluated several years before diagnosis may be associated with lower risk of subsequent ovarian cancer in women &lt;64 years old at assessment. Impact: Key elements of an “immune model” to explain ovarian cancer risk factors are confirmed and should be evaluated in larger prospective studies. Cancer Epidemiol Biomarkers Prev; 19(6); 1595–601. ©2010 AACR." @default.
• W2160022288 created "2016-06-24" @default.
• W2160022288 creator A5003642463 @default.
• W2160022288 creator A5008373933 @default.
• W2160022288 creator A5024170610 @default.
• W2160022288 creator A5054091966 @default.
• W2160022288 creator A5061753517 @default.
• W2160022288 creator A5076775160 @default.
• W2160022288 creator A5089191285 @default.
• W2160022288 date "2010-06-01" @default.
• W2160022288 modified "2023-09-26" @default.
• W2160022288 title "Anti-MUC1 Antibodies and Ovarian Cancer Risk: Prospective Data from the Nurses' Health Studies" @default.
• W2160022288 cites W1521030336 @default.
• W2160022288 cites W1915721030 @default.
• W2160022288 cites W1964375677 @default.
• W2160022288 cites W1969456163 @default.
• W2160022288 cites W1978014946 @default.
• W2160022288 cites W1982785558 @default.
• W2160022288 cites W1991466268 @default.
• W2160022288 cites W2000175691 @default.
• W2160022288 cites W2002296736 @default.
• W2160022288 cites W2015220984 @default.
• W2160022288 cites W2028656900 @default.
• W2160022288 cites W2032236898 @default.
• W2160022288 cites W2053992883 @default.
• W2160022288 cites W2067187780 @default.
• W2160022288 cites W2080174371 @default.
• W2160022288 cites W2094165794 @default.
• W2160022288 cites W2097017143 @default.
• W2160022288 cites W2112241054 @default.
• W2160022288 cites W2112486118 @default.
• W2160022288 cites W2117354976 @default.
• W2160022288 cites W2117871594 @default.
• W2160022288 cites W2119964825 @default.
• W2160022288 cites W2122100237 @default.
• W2160022288 cites W2124330545 @default.
• W2160022288 cites W2137303334 @default.
• W2160022288 cites W2142647903 @default.
• W2160022288 cites W2149401276 @default.
• W2160022288 cites W2165661271 @default.
• W2160022288 cites W2417178025 @default.
• W2160022288 doi "https://doi.org/10.1158/1055-9965.epi-10-0068" @default.
• W2160022288 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2887719" @default.
• W2160022288 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20501761" @default.
• W2160022288 hasPublicationYear "2010" @default.
• W2160022288 type Work @default.
• W2160022288 sameAs 2160022288 @default.
• W2160022288 citedByCount "44" @default.
• W2160022288 countsByYear W21600222882012 @default.
• W2160022288 countsByYear W21600222882013 @default.
• W2160022288 countsByYear W21600222882014 @default.
• W2160022288 countsByYear W21600222882015 @default.
• W2160022288 countsByYear W21600222882016 @default.
• W2160022288 countsByYear W21600222882017 @default.
• W2160022288 countsByYear W21600222882018 @default.
• W2160022288 countsByYear W21600222882020 @default.
• W2160022288 countsByYear W21600222882021 @default.
• W2160022288 countsByYear W21600222882022 @default.
• W2160022288 crossrefType "journal-article" @default.
• W2160022288 hasAuthorship W2160022288A5003642463 @default.
• W2160022288 hasAuthorship W2160022288A5008373933 @default.
• W2160022288 hasAuthorship W2160022288A5024170610 @default.
• W2160022288 hasAuthorship W2160022288A5054091966 @default.
• W2160022288 hasAuthorship W2160022288A5061753517 @default.
• W2160022288 hasAuthorship W2160022288A5076775160 @default.
• W2160022288 hasAuthorship W2160022288A5089191285 @default.
• W2160022288 hasBestOaLocation W21600222881 @default.
• W2160022288 hasConcept C121608353 @default.
• W2160022288 hasConcept C126322002 @default.
• W2160022288 hasConcept C131872663 @default.
• W2160022288 hasConcept C143998085 @default.
• W2160022288 hasConcept C148759681 @default.
• W2160022288 hasConcept C159654299 @default.
• W2160022288 hasConcept C188816634 @default.
• W2160022288 hasConcept C203014093 @default.
• W2160022288 hasConcept C2777421810 @default.
• W2160022288 hasConcept C2780427987 @default.
• W2160022288 hasConcept C29456083 @default.
• W2160022288 hasConcept C44249647 @default.
• W2160022288 hasConcept C68443243 @default.
• W2160022288 hasConcept C71924100 @default.
• W2160022288 hasConcept C82789193 @default.
• W2160022288 hasConcept C90924648 @default.
• W2160022288 hasConceptScore W2160022288C121608353 @default.
• W2160022288 hasConceptScore W2160022288C126322002 @default.
• W2160022288 hasConceptScore W2160022288C131872663 @default.
• W2160022288 hasConceptScore W2160022288C143998085 @default.
• W2160022288 hasConceptScore W2160022288C148759681 @default.
• W2160022288 hasConceptScore W2160022288C159654299 @default.
• W2160022288 hasConceptScore W2160022288C188816634 @default.
• W2160022288 hasConceptScore W2160022288C203014093 @default.
• W2160022288 hasConceptScore W2160022288C2777421810 @default.
• W2160022288 hasConceptScore W2160022288C2780427987 @default.
• W2160022288 hasConceptScore W2160022288C29456083 @default.
• W2160022288 hasConceptScore W2160022288C44249647 @default.
• W2160022288 hasConceptScore W2160022288C68443243 @default.
• W2160022288 hasConceptScore W2160022288C71924100 @default.
• W2160022288 hasConceptScore W2160022288C82789193 @default.

• next